Pennsylvania Cannabis
Market Intelligence Report

Pennsylvania's medical cannabis program has grown into one of the largest cannabis retail markets in the country — medical-only or otherwise. The program generated $453.3 million in sales in the first quarter of 2026 alone, up 6% from the same period a year earlier, and has surpassed $9.1 billion in cumulative sales since launch, making it the nation's sixth-largest cannabis retail market by total sales. The dispensary network has more than doubled since 2020, from 86 locations to 185 today, serving 439,381 active patients as of November 2025.

That scale has fueled renewed momentum for adult-use legalization. The Pennsylvania House passed HB 1200 in May 2025, but the Senate Law and Justice Committee voted 7-3 to table the bill just days later, ending its progress for the session. Two new bipartisan bills favoring a private-store model, SB 120 and HB 20, followed in July 2025. The political pressure is amplified by geography: Pennsylvania is now bordered by five adult-use states (New York, New Jersey, Ohio, Maryland, and Delaware) and just one other medical-only state (West Virginia) — a uniquely adult-use-surrounded position among medical-only states nationally.

Pennsylvania's population of over 13 million — the nation's fifth-most-populous state — supports a medical patient base of roughly 3-4% of all residents, a registration rate consistent with mature medical programs nationally. (Official, Census ACS 2024)

The Pennsylvania Department of Health's Office of Medical Marijuana regulates the state's medical program, which has grown its dispensary network from 86 locations in 2020 to 185 today. No adult-use retail licensing framework currently exists: HB 1200 passed the House in May 2025 but was tabled by the Senate Law and Justice Committee on a 7-3 vote, and two newer bipartisan bills (SB 120, HB 20) favoring a private-store model remain pending as of the most recent legislative session.

Pennsylvania's pending adult-use legalization proposals include dedicated funding mechanisms aimed at restorative justice and small-business support, contingent on the legislature passing a bill.

Pennsylvania's medical cannabis supply chain has scaled to support $9.1 billion in cumulative sales and a 185-dispensary retail network, reflecting cultivation and processing infrastructure built out over nearly a decade of program operation. This existing supply base is widely viewed by industry observers as well-positioned to convert toward adult-use production volumes relatively quickly if legalization passes, given its already-substantial scale.

Pennsylvania's medical cannabis demand has shown steady, healthy growth even as the program matures, with Q1 2026 sales up 6% year-over-year and December typically the strongest month of the year.

Pennsylvania's 185 dispensaries are distributed across the state's major population centers, with the largest concentrations around Philadelphia, Pittsburgh, and the Lehigh Valley. The Department of Health does not publish an official county-by-county dispensary count. (Not Available — county-level breakdown.)

Pennsylvania's cost structure is split between today's established medical-only economics and an unresolved adult-use framework still working through the legislature.

Vendor demand signal tracks which product and service categories Pennsylvania's medical dispensaries are actively sourcing this quarter.

Pennsylvania levies a 5% tax on medical cannabis at the grower/processor wholesale level, which is generally passed through rather than charged as a separate retail excise tax to patients. No adult-use tax structure exists yet since legalization has not passed; the governor's proposal estimates that an adult-use program could generate roughly $250 million annually in tax revenue, or $1.3 billion over five years, as the market matures.

Pennsylvania is now bordered by five adult-use states and one other medical-only state — one of the most adult-use-surrounded positions of any medical-only state in the country, and a frequently cited argument by legalization advocates in Harrisburg.

The Department of Health does not publish a consolidated statewide cannabis-industry employment figure; given 185 dispensaries plus associated cultivation and processing operations supporting $9.1 billion in cumulative sales, total industry employment is likely substantial, though no official total is available. (Not Available.)

Pennsylvania's pending adult-use legalization proposals include immediate expungement for possession-only offenses and a $25 million fund for small and diverse businesses; neither is in effect under the current medical-only program. (Official, proposal — not yet enacted.)

Pennsylvania does not publish an official illicit cannabis market size estimate. Legalization advocates frequently cite cross-border sales leakage to neighboring adult-use states as a policy argument, though no official dollar figure quantifies this effect for Pennsylvania specifically. (Not Available.)

This report blends official Pennsylvania Department of Health program data with legislative records and reputable cannabis policy media reporting on pending adult-use bills.

This report compiles data from the Pennsylvania Department of Health, the Pennsylvania General Assembly's legislative records, federal demographic sources, and reputable cannabis industry and policy media.